Pull to refresh
Logo
Daily Brief
Following
Why
American Academy of Pediatrics (AAP)

American Academy of Pediatrics (AAP)

Professional Association

Appears in 2 stories

Stories

US hepatitis B birth-dose policy upended by new vaccine advisory panel

Rule Changes

The American Academy of Pediatrics represents tens of thousands of pediatricians and issues influential clinical guidelines on child health, including immunization policy. - Maintains recommendation that all newborns get hepatitis B vaccine within 24 hours

In December 2025, the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP)—reconstituted by Health and Human Services Secretary Robert F. Kennedy Jr.—voted 8–3 to end the universal recommendation for hepatitis B vaccination within 24 hours of all US newborns’ birth. On December 16, 2025, Acting CDC Director Jim O’Neill formally adopted the recommendation, shifting to individual-based or shared clinical decision-making for infants of mothers testing negative for hepatitis B, with any first dose suggested no earlier than two months old; birth doses remain advised for infants of positive or unknown-status mothers.

Updated Feb 6

ACIP moves to end universal hepatitis B shots at birth

Rule Changes

AAP represents U.S. pediatricians and develops clinical policy statements on child health, including immunization recommendations. - Opposes ending universal hepatitis B birth dose; continues to recommend vaccination within 24 hours

On December 5, 2025, the Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP)—recently overhauled under Health and Human Services Secretary Robert F. Kennedy Jr.—voted 8–3 to end the longstanding recommendation that every U.S. newborn receive a hepatitis B vaccine dose within 24 hours of birth. For babies whose mothers test negative for hepatitis B, the panel now advises individualized decision-making with parents and suggests delaying the first dose until at least two months of age, while retaining the birth dose for infants whose mothers are infected or whose status is unknown; acting CDC Director Jim O’Neill ratified this on December 16, 2025.

Updated Feb 5